Genpact Limited Form 4 Filings

Genpact LTD (G) reported that Senior Vice President Sameer Dewan sold a total of 14,972 Common Shares on 2026-08-14 in open market or private transactions. One block of 1,654 shares was sold at $34.10 per share, and another block of 13,318 shares was sold at a weighted average price of $34.10, with sales prices ranging from $34.10 to $34.11. Post-transaction share holdings were not reported in this filing.

Genpact LTD Chief Financial Officer Michael Hal Weiner reported a sale of 5,900 Common Shares on August 13, 2026 in an open-market or private transaction at $34.04 per share. Following this sale, he directly holds 176,027 Common Shares, including 1,591 shares under the Genpact Employee Stock Purchase Plan, of which 53 ESPP shares were acquired since his March 12, 2026 ownership report.

Genpact LTD Senior Vice President Nanduru Anil reported two open-market sales of common shares. On August 11, 2026, he sold 17,243 shares at a weighted average price of $33.96 per share, with actual prices ranging from $33.95–$33.99. On August 12, 2026, he sold 11,852 shares at a weighted average price of $33.92, with actual prices from $33.90–$33.94. The transactions were reported as direct ownership sales and are not indicated as being under a Rule 10b5-1 trading plan.

Hinshaw John M reported acquisition or exercise transactions in this Form 4 filing.

Genpact LTD director John M. Hinshaw received an equity award in the form of restricted share units. He was granted 6,521 unvested RSUs, each entitling him to one common share in the future. Subject to his continued service, these RSUs will fully vest on December 31, 2026 and will be settled in common shares on December 31, 2027. Following this grant, he holds 8,855 common shares directly.

Morken CeCelia reported acquisition or exercise transactions in this Form 4 filing.

Genpact Ltd director CeCelia Morken received an equity grant in the form of restricted share units (RSUs). The award covers 6,521 common shares granted at no cash cost under the Genpact Limited 2017 Omnibus Incentive Compensation Plan. Each RSU entitles her to one common share at a future date, subject to continued service. The RSUs will fully vest on December 31, 2026 and will be settled in common shares on December 31, 2027. Following this grant, she directly holds 64,281 common shares.

Genpact LTD director Carol Lindstrom received an equity award of 6,521 common-share RSUs. The grant, priced at $0.00 per unit as compensation, increases her direct holdings to 27,706 common shares after the award. Each restricted share unit entitles her to one common share at a future date.

According to the award terms, all RSUs will fully vest on December 31, 2026, assuming she continues in service, and will be settled in common shares on December 31, 2027. This is a non-market, compensation-related acquisition rather than an open-market purchase.

Gangestad Nicholas C reported acquisition or exercise transactions in this Form 4 filing.

Genpact LTD director Nicholas C. Gangestad received an equity grant in the form of restricted share units. He was awarded 6,521 unvested RSUs, each representing one common share at a future date, increasing his direct holdings to 15,334 common shares after the award.

The RSUs were granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan. Subject to his continued service, the entire RSU award will vest on December 31, 2026 and will be settled in common shares on December 31, 2027, aligning his compensation further with long-term shareholder interests.

Subaiya Thimaya K. reported acquisition or exercise transactions in this Form 4 filing.

Genpact LTD director Subaiya Thimaya K. received a compensation grant of 6,521 unvested restricted share units (RSUs) of common shares at no cash cost. Each RSU represents one future Genpact common share. Subject to continued service, all RSUs will vest on December 31, 2026 and be settled in common shares on December 31, 2027. Following this award, the director holds 8,541 common shares directly, including the unvested RSUs reported in this filing.

Verdi Mark A reported acquisition or exercise transactions in this Form 4 filing.

Genpact LTD director Mark A. Verdi reported a compensation-related share grant. He received 6,521 unvested restricted share units (RSUs), with each RSU representing one common share granted at no cash cost. These RSUs fully vest on December 31, 2026 and will be settled in common shares on December 31, 2027. Following this award, Verdi directly holds 71,526 common shares.

Genpact Limited director Brian Mark Stevens received an equity award in the form of restricted share units. He acquired 6,521 common shares at a price of $0.00 per share through a grant classified as a non-derivative award. Following this award, his direct holdings increased to 36,619 common shares.

The grant represents unvested restricted share units (RSUs) under the Genpact Limited 2017 Omnibus Incentive Compensation Plan. Each RSU entitles him to one common share. Subject to his continued service, the RSUs will fully vest on December 31, 2026 and will be settled in common shares on December 31, 2027.

Conigliaro Laura reported acquisition or exercise transactions in this Form 4 filing.

Genpact LTD director Laura Conigliaro received an equity award of 6,521 unvested restricted share units (RSUs). The grant was made in the form of common share RSUs under the Genpact Limited 2017 Omnibus Incentive Compensation Plan as part of her director compensation.

Each RSU entitles her to receive one common share at a future date. The RSUs are scheduled to fully vest on December 31, 2026, assuming she continues in service, and will be settled in common shares on December 31, 2027. Following this grant, she directly holds 79,337 common shares.

Madden James C. reported acquisition or exercise transactions in this Form 4 filing.

Genpact LTD director James C. Madden received an equity award of 9,999 restricted share units (RSUs) of common shares. The award was granted at no cash cost per unit and increases his directly held common share interest to 73,067 shares.

Each RSU represents the right to receive one common share in the future. Subject to his continued service, all RSUs will fully vest on December 31, 2026, and will be settled in common shares on December 31, 2027, under the Genpact Limited 2017 Omnibus Incentive Compensation Plan.

Genpact LTD Chief Financial Officer Michael Hal Weiner reported a tax-related share disposition linked to equity compensation. On the vesting of performance share units granted on March 15, 2023, 7,019 common shares were withheld at $38.92 per share to cover tax obligations. Following this non-market transaction, he holds 181,874 common shares directly.

Genpact Limited Senior Vice President Riju Vashisht reported a tax-related share disposition. On this Form 4, 7,080 common shares were withheld at $38.92 per share to cover taxes due upon vesting of performance share units granted on March 15, 2023. After this withholding, Vashisht directly holds 123,668 Genpact common shares.

Genpact LTD Senior Vice President Anil Nanduru reported a routine tax-withholding transaction related to equity compensation. On this Form 4, 7,663 common shares were withheld at a price of $38.92 per share to cover taxes due upon the vesting of performance share units granted on March 15, 2023 under Genpact’s 2017 Omnibus Incentive Compensation Plan. After this non-market disposition, Nanduru directly holds 105,539 common shares, indicating the filing reflects compensation-related tax settlement rather than an open-market sale.

Genpact Limited reported a routine compensation-related share withholding for its Senior Vice President and CHRO, Piyush Mehta. On March 10, 5,702 common shares were withheld at $38.92 per share to cover taxes upon vesting of performance share units granted on March 15, 2023. Following this tax-withholding disposition, Mehta directly holds 156,485 common shares, reflecting his ongoing equity stake in the company rather than an open-market sale.

Genpact Limited Senior Vice President Sameer Dewan reported a tax-related share disposition tied to equity compensation. On this Form 4, 3,542 common shares were withheld at a value of $38.92 per share to cover taxes upon vesting of performance share units granted on March 15, 2023.

After this withholding, Dewan directly holds 57,665 common shares. This transaction reflects routine tax withholding on vested performance-based awards under the Genpact Limited 2017 Omnibus Incentive Compensation Plan rather than an open-market purchase or sale decision.

Genpact Limited President and CEO Balkrishan Kalra reported a tax-related share withholding. On the vesting of performance share units granted on March 15, 2023, 13,893 common shares were withheld to cover tax obligations, rather than sold in the market. Following this non-market disposition, he continues to hold 511,114 common shares directly.

Genpact Ltd President and CEO Balkrishan Kalra reported multiple equity transactions. On March 4, 2026, he exercised an employee stock option for 2,800 common shares at $27.65 per share, then sold 2,800 common shares in an open‑market transaction at a weighted average price of $40.77, leaving 525,007 common shares held directly afterward.

On March 3, 2026, he also acquired 27,160 common shares as a grant or award at no cost, increasing his direct holdings. Footnotes note performance share units granted on March 15, 2023 that will vest on March 10, 2026, and 8,962 shares currently held under the employee stock purchase plan, including 587 shares bought since his prior Form 4.

Genpact LTD reported that Senior Vice President Sameer Dewan acquired 6,928 common shares through a grant/award transaction at a price of $0.00 per share. Following this award, he directly holds 61,207 common shares.

These shares relate to performance share units granted on March 15, 2023, for which the performance conditions have been satisfied. Each unit represents the right to receive one common share, and the units will vest on March 10, 2026, subject to his continued service.

Genpact LTD Senior Vice President and CHRO Piyush Mehta reported an equity award of 14,618 common shares. The shares relate to performance share units granted on March 15, 2023, for which performance conditions have been satisfied. These PSUs will vest on March 10, 2026, if he continues in service through that date.

Following this grant, Mehta directly holds 162,187 common shares, including 10,512 shares under Genpact’s Employee Stock Purchase Plan, of which 153 were acquired since his prior Form 4 filed on February 3, 2026.

Nanduru Anil reported acquisition or exercise transactions in this Form 4 filing.

Genpact LTD Senior Vice President Nanduru Anil reported an equity award of 13,856 common shares. These shares relate to performance share units granted on March 15, 2023, for which the performance conditions have been satisfied.

Each PSU represents the right to receive one common share. The units are scheduled to vest on March 10, 2026, subject to the executive’s continued service through that date. Following this award, Anil’s directly held stake is reported as 113,202 common shares.

Genpact LTD reported that Senior Vice President Riju Vashisht acquired 13,856 common shares at no cost through the settlement of performance share units granted on March 15, 2023. The transaction increased her directly held stake to 130,748 common shares.

The underlying performance share units will vest on March 10, 2026, subject to her continued service, with each unit representing the right to receive one common share.

Genpact LTD’s Chief Financial Officer, Michael Hal Weiner, reported acquiring 17,320 common shares on March 3, 2026 through a grant/award transaction at a price of $0.00 per share. These shares relate to performance share units granted on March 15, 2023, for which performance conditions have been satisfied. The performance share units will vest on March 10, 2026, subject to his continued service. Following this award, he beneficially owns 188,893 common shares, including 1,538 shares held under the Genpact Employee Stock Purchase Plan, of which 102 were acquired since his Form 4 filed on February 3, 2026.

Genpact Limited’s Chief Accounting Officer, Anthony J. Radesca, received an equity grant of 6,802 common shares on January 30, 2026, at a price of $0 per share. The award is in the form of restricted share units under the Genpact Limited 2017 Omnibus Incentive Compensation Plan.

Each RSU converts into one Genpact common share upon vesting. One-third of the shares will vest on each of January 10, 2027, January 10, 2028, and January 10, 2029, contingent on his continued service. Following this grant, he beneficially owns 26,868 common shares directly.

Genpact Limited reported that SVP and Chief Legal Officer Sydney Schaub received an equity award in the form of restricted share units. On January 30, 2026, Schaub was granted 12,471 common shares at a price of $0, increasing her directly held beneficial ownership to 75,828 common shares.

The award consists of unvested restricted share units granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan. Each RSU converts into one common share upon vesting. One-third of the RSUs will vest on each of January 10, 2027, January 10, 2028, and January 10, 2029, subject to her continued service through each vesting date.

Genpact Limited Senior Vice President Sameer Dewan reported an equity award of 16,530 common share units on January 30, 2026. The filing shows these shares at a price of $0, reflecting a grant of unvested restricted share units under the Genpact Limited 2017 Omnibus Incentive Compensation Plan.

Each RSU converts into one Genpact common share as it vests. One-third of the award will vest on each of January 10, 2027, January 10, 2028, and January 10, 2029, contingent on continued service. Following this grant, Dewan beneficially owns 54,279 common shares directly.

Genpact Limited Senior Vice President Anil Nanduru received an equity award of 21,371 common shares in the form of restricted share units on January 30, 2026. The award was granted at a price of $0 per share and increased his beneficially owned common shares to 99,346, held directly.

The RSUs were granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan. Each RSU converts into one common share upon vesting. One-third of the shares will vest on each of January 10, 2027, January 10, 2028, and January 10, 2029, if he continues in service through each vesting date.

Genpact Limited’s President and CEO, Balkrishan Kalra, reported an equity compensation grant in the form of restricted share units. On January 30, 2026, he was awarded 106,575 common shares at a price of $0 per share, increasing his beneficial ownership to 497,260 common shares, held directly.

The award represents unvested restricted share units under the Genpact Limited 2017 Omnibus Incentive Compensation Plan. Each RSU converts into one common share upon vesting. One-third of the shares will vest on each of January 10, 2027, January 10, 2028 and January 10, 2029, contingent on his continued service through each vesting date.

Genpact Limited reported that Senior Vice President and Chief Human Resources Officer Piyush Mehta received an award of 24,716 common shares on January 30, 2026 at a price of $0 per share, reflecting a grant under the company’s 2017 Omnibus Incentive Compensation Plan.

The award represents unvested restricted share units, each convertible into one common share upon vesting. One-third of the units will vest on each of January 10, 2027, January 10, 2028 and January 10, 2029, subject to Mehta’s continued service. Following this grant, he beneficially owns 147,416 common shares directly.

Genpact Limited reported that Senior Vice President Riju Vashisht received an equity award of 21,371 common-share RSUs on January 30, 2026 at a price of $0 per share, reflecting a stock-based compensation grant rather than an open-market purchase.

Following this award, Vashisht beneficially owns 116,892 Genpact common shares in total. The RSUs vest in three equal installments, with one-third vesting on January 10, 2027, one-third on January 10, 2028, and the final third on January 10, 2029, subject to continued service.

Genpact Limited’s Chief Financial Officer Michael Hal Weiner received an equity award of 35,396 common shares on January 30, 2026. The award was granted at a price of $0 per share in the form of restricted share units under the Genpact Limited 2017 Omnibus Incentive Compensation Plan.

Each RSU converts into one common share upon vesting. One-third of the shares are scheduled to vest on each of January 10, 2027, January 10, 2028 and January 10, 2029, conditioned on his continued service. Following this grant, he beneficially owned 171,471 common shares in total.

Genpact Ltd President and CEO Balkrishan Kalra reported a tax‑withholding transaction involving 29,691 common shares. On 01/10/2026, 29,691 Genpact common shares were withheld at a price of $48.24 per share to pay taxes due upon the vesting of restricted share units granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan, in a transaction coded "F" and exempt under Rule 16b-3.

After this withholding, Kalra directly holds 390,685 common shares of Genpact. This event reflects shares being retained by the company for tax purposes rather than an open-market sale.

Genpact Ltd senior vice president Sameer Dewan reported two transactions in Genpact common shares. On January 10, 2026, 9,780 shares were withheld at $48.24 per share to cover taxes upon the vesting of restricted share units granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan. After this withholding, Dewan beneficially owned 52,837 shares directly.

On January 13, 2026, Dewan sold 15,088 common shares at a weighted average price of $46.65 per share, with actual sale prices ranging from $46.40 to $47.05. These sales were made under a Rule 10b5-1 trading plan adopted on September 15, 2025. Following the sale, Dewan directly held 37,749 Genpact common shares.

Genpact Limited senior vice president Anil Nanduru reported a tax-related share withholding tied to equity compensation. On January 10, 2026, 11,871 common shares of Genpact Limited were withheld at a price of $48.24 per share. The filing explains these shares were withheld to pay taxes upon the vesting of restricted share units granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan and are exempt under Rule 16b-3.

After this transaction, Nanduru beneficially owned 77,975 common shares, held directly. The activity reflects routine tax withholding on vested stock awards rather than an open-market purchase or sale.

Genpact Limited senior vice president Riju Vashisht reported two transactions in the company’s common shares. On January 10, 2026, 10,733 shares were withheld to cover taxes upon vesting of restricted share units under the Genpact Limited 2017 Omnibus Incentive Compensation Plan at a price of $48.24 per share. This was a tax-related withholding rather than an open-market sale.

On January 13, 2026, Vashisht sold 16,016 common shares at a weighted average price of $46.65 per share, with actual prices ranging from $46.40 to $47.05. These sales were executed under a pre-established Rule 10b5-1 trading plan adopted on September 11, 2025. After these transactions, Vashisht directly held 95,521 Genpact common shares.

Genpact LTD executive Piyush Mehta reported a routine tax-related share withholding. On 01/10/2026, 12,317 common shares were withheld at $48.24 per share to cover taxes due upon the vesting of restricted share units granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan, in a transaction exempt under Rule 16b-3.

After this transaction, Mehta directly beneficially owned 122,700 Genpact common shares. The filing also notes participation in the Genpact Employee Stock Purchase Plan, including 137 shares acquired since a prior Form 4, with a current total of 10,359 shares held under the ESPP.

Genpact Ltd’s Chief Financial Officer Michael Hal Weiner reported a routine tax-related share transaction. On January 10, 2026, 12,029 common shares were withheld at $48.24 per share to cover taxes due upon the vesting of restricted share units granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan, a transaction noted as exempt under Rule 16b-3. Following this withholding, Weiner beneficially owns 136,075 common shares directly. This total includes shares accumulated through the Genpact Employee Stock Purchase Plan, where he currently holds 1,436 shares, including 78 shares acquired since his prior Form 4 filed on November 17, 2025.

Genpact Limited reported that its SVP and Chief Legal Officer, Sydney Schaub, received an award of 63,357 common shares in the form of unvested restricted share units on 01/06/2026 at a grant price of $0 per share. Each RSU represents the right to receive one Genpact common share upon vesting. One-third of the shares underlying this RSU award will vest on each of December 8, 2026, December 8, 2027 and December 8, 2028, as long as Schaub continues in service through each vesting date. Following this grant, Schaub beneficially owned 63,357 common shares directly.

Genpact Limited reported an insider equity award to its President and CEO, who is also a director. On December 17, 2025, the executive received 125,130 restricted share units (RSUs) of Genpact common shares at a price of $0 per share, granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan. Each RSU converts into one common share when it vests.

One-third of the shares underlying this RSU award will vest on each of December 17, 2026, December 17, 2027 and December 17, 2028, contingent on the executive’s continued service through each vesting date. After this transaction, the executive beneficially owns 420,376 Genpact common shares directly.

Genpact Ltd (G) reported that its Chief Financial Officer filed a Form 4 disclosing an open-market sale of company stock. On 11/14/2025, the CFO sold 13,365 common shares of Genpact at a weighted average price of $44.84 per share, with individual sale prices ranging from $44.81 to $44.89. Following this transaction, the reporting person beneficially owns 148,026 Genpact common shares. This total includes 1,358 shares held under the Genpact Employee Stock Purchase Plan, of which 169 shares were acquired under the plan since a prior report filed on March 13, 2025.

Genpact (G) reported insider transactions by its SVP & Chief Legal Officer. On 11/11/2025, the officer sold 1,039 common shares at $44.02. On 11/12/2025 and 11/13/2025, the officer exercised employee stock options at $27.7 for 4,351 and 45,703 shares, respectively, and sold the corresponding shares at $45.74. Following these transactions, the officer directly beneficially owned 50,569 common shares. The reported option grant was scheduled to expire on 01/09/2029 and vested 50% on January 10, 2022 and 50% on January 10, 2024.

Genpact Ltd (G) — Form 4 insider transaction: Senior Vice President Sameer Dewan reported a sale of 26,531 common shares on 11/11/2025, coded “S” for sale. The weighted average price was $44.7, with disclosed trade prices ranging from $44.70 to $44.7305.

Following the transaction, Dewan beneficially owns 62,617 shares, held directly.

Genpact Ltd (G) director Tamara Franklin reported a sale of 2,750 common shares at $45.65 on November 12, 2025, according to a Form 4 filing. Following the transaction, she beneficially owns 22,236 shares, held directly. The filing lists a transaction code “S,” indicating a sale, and shows no derivative securities activity reported.

Genpact Ltd (G) reported an equity award to an officer. On 10/10/2025, the Chief Accounting Officer acquired 20,066 common shares at $0, reported as an award of unvested restricted share units under the Genpact Limited 2017 Omnibus Incentive Compensation Plan. Following the transaction, beneficial ownership was 20,066 shares, held directly.

Each RSU converts into one common share upon vesting. The award vests in three equal installments on April 30, 2027, July 31, 2027, and October 31, 2027, subject to continued service through each vesting date.

Insider transactions by Genpact Ltd (G): Senior Vice President and CHRO Piyush Mehta executed multiple transactions on 09/12/2025. He acquired 50,000 common shares at $31.50, and sold 50,000 shares and 26,902 shares at weighted-average prices of $42.58 (sales ranged from $42.42 to $42.73 and $42.42 to $42.70 respectively). After these transactions he beneficially owns 134,880 common shares. The filing notes he holds 10,222 shares under the ESPP (including 284 shares acquired since his prior Form 4). The Form 4 was signed by an attorney-in-fact on 09/15/2025.

Insider transactions by Genpact Ltd director and CEO Balkrishan Kalra. On 09/11/2025 Mr. Kalra sold 15,000 common shares at a weighted-average price of approximately $43.39 and sold 40,000 common shares at a weighted-average price of approximately $43.35, reducing his reported beneficial ownership to 295,246 shares. On the same date he acquired 40,000 common shares by exercising employee stock options at a $27.65 exercise price, bringing his beneficial ownership to 335,246 shares before the net sales shown. The Form 4 shows the option originally vested in two tranches (50% on 01/10/2019 and the remainder on 01/10/2021) and lists 40,000 underlying shares exercised with 2,800 derivative securities remaining reported as beneficially owned. Transactions were signed by an attorney-in-fact on 09/15/2025.